Morphic Holding
Latest round
- Series B
Last raised
- Sep 2018
Total raised
- $132M
Investors
- 7
About Morphic Holding
Morphic Holding, Inc.S.Founded in 2014 and headquartered in Waltham, Massachusetts, Morphic Holding, Inc. focuses on advancing integrin-based therapeutics.00 mn, primarily from Eli Lilly and Company. The founder, Timothy Springer, has a notable history in the biopharmaceutical sector, contributing to several prior ventures.Morphic Holding, Inc. is focused on developing oral integrin therapies aimed at treating chronic diseases such as inflammatory bowel disease. Its product candidates are designed to offer advanced treatment options that address significant unmet medical needs in various therapeutic areas.In the most recent fiscal year of 2022, Morphic Holding, Inc.Morphic Holding, Inc. The company is also exploring expansion into international markets, targeting Europe and Asia for potential growth by 2023. The recent capital influx will support the development and manufacturing processes essential for bringing new products to market, showcasing the firm’s commitment to advancing its therapeutic portfolio.
Who invested in Morphic Holding
7 investors across 2 rounds
See all investors in Morphic Holding
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Morphic Holding
Who invested in Morphic Holding?
Morphic Holding has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Morphic Holding raised?
Morphic Holding has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Morphic Holding last raise money?
Morphic Holding's most recent round on record is a Series B, in Sep 2018.
What does Morphic Holding do?
Morphic Holding is a biotechnology company.
Where is Morphic Holding headquartered?
Morphic Holding is headquartered in Waltham, US.
Which VCs invest in companies like Morphic Holding?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Morphic Holding's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Morphic Holding? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.